Flat intraepithelial lesions of the urinary bladder

Cancer

Volumn 88, Issue 3, 2000, Pages 625-631

  Cheng, Liang ^a   Cheville, John C ^b   Neumann, Roxann M ^b   Bostwick, David G ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c BOSTWICK LABORATORIES   (United States)

Author keywords

Atypia; Carcinoma in situ; Detection; Dysplasia; Grading; Neoplasms; Precursor; Progression; Screening; Urinary bladder

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CELL PROLIFERATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; PROGNOSIS; RISK FACTORS; SEX FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM; WORLD HEALTH ORGANIZATION;

EID: 0034141794     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.0.CO;2-A     Document Type: Article

References (27)

1. Epstein JI, Amin MB, Reuter VR, Mostofi FK, the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22: 1435-8.
2. Cheng L, Cheville JC, Leibovich BC, Weaver AL, Egan KS, Spotts BE, et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 1999;85:2469-74.
3. Cheng L, Cheville JC, Newman RM, Bostwick DG. Natural history of urothelial dysplasia of the bladder. Am J Surg Pathol 1999;23:443-7.
4. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC cancer staging manual. Philadelphia: Lippincott-Raven, 1997.
5. Zuk R, Rogers H, Martin J, Baithun S. Clinicopathological importance of primary dysplasia of bladder. J Clin Pathol 1988;41:1277-80.
6. Baithun S, Rogers H, Martin J, Zuk R, Blandy J. Primary dysplasia of bladder. Lancet 1988;1:483.
7. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
8. Robertson A, Beck J, Burnett R, Howatson S, Lee F, Lessells A, et al. Observer variability in histopathological reporting of transitional cell carcinoma and epithelial dysplasia in bladders. J Clin Pathol 1990;43:17-21.
9. Fradet Y, Lafleur L, LaRue H. Strategies of chemoprevention based on antigenic and molecular markers of early and premalignant lesions of the bladder. J Cell Biochem 1992; 161:85-92.
10. Droller MJ. Bladder cancer: state-of-the-art care. CA Cancer J Clin 1998;48:269-84.
11. Koss LG. Tumors of the urinary bladder. Fascicle 11. Washington, D.C.: Armed Forces Institute of Pathology, 1975.
12. Mostofi FK, Sesterhenn IA. Pathology of epithelial tumors and carcinoma in situ of the bladder. Prog Clin Biol Res 1984;162A:55-74.
13. Murphy WM. Atlas of bladder carcinoma. Chicago: American Society of Clinical Pathologists Press, 1986.
14. Nagy G, Frable W, Murphy W. Classification of premalignant urothelial abnormalities: a Delphi study of the National Bladder Cancer Collaborative Group A. Pathol Annu 1982; 17:219-33.
15. Friedell G, Soloway M, Hilgar A, Farrow G. Summary of workshop on carcinoma in situ of the bladder. J Urol 1986; 136:1047-8.
16. Koss LG, Woyke S, Olszewski W. Aspiration biopsy: cytologic interpretation and histologic bases. New York: Igaku Shoin, 1992.
17. Reuter VE, Melamed MR. Diagnostic surgical pathology. In: Sternberg SS, editor. Diagnostic surgical pathology. 1st edition. New York: Raven Press, 1989:1355-92.
18. Grignon DJ. Neoplasm of the urinary bladder. In: Bostwick DG, Eble JN, editors. Urologic surgical pathology. St. Louis: Mosby-Year Book, 1997:215-306.
19. Murphy W, Soloway M. Urothelial dysplasia. J Urol 1982; 127:849-54.
20. Murphy W, Soloway M. Developing carcinoma (dysplasia) of the urinary bladder. Pathol Annu 1982;17:197-217.
21. Harnden P, Earley I, Joyce A, Southgate J. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 1996; 78:870-5.
22. Sanchez-Fernandez de Sevilla M, Morell-Quadreny L, Gil-Salom M, Perez-Bacete M, Llombart-Bosch A. Morphometric and immunohistochemical characterization of bladder carcinoma in situ and its preneoplastic lesions. Eur Urol 1992;21:5-9.
23. Soini Y, Turpeenniemi-Hujanen T, Kamel D, Autio-Harmainen H, Risteli J, Risteli L, et al. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Br J Cancer 1993;68:1029-35.
24. Schmitz-Drager B, Van Roeyen C, Grimm M, Gerhatz C, Decken K, Schulz W, et al. p53 accumulation in precursor lesions and early stages of bladder cancer. World J Urol 1994;12:79-83.
25. Wagner U, Sauter G, Moch H, Novotna H, Epper R, Mihatsch M, et al. Patterns of p53, erb B-2, and EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 1995;26:970-8.
26. Bostwick DG, Ramnani D, Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol Clin North Am 1999;26:493-507.
27. Orozco R, Martin A, Murphy W. Carcinoma in situ of the urinary bladder: clues to host involvement in human carcinogenesis. Cancer 1994;74:115-22.